Randomized trial · people

NMN raised serum nicotinamide over 12 weeks in middle-aged adults

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In healthy middle-aged adults, 12 weeks of NMN raised one NAD+-related blood marker without side effects, but it did not significantly change arterial stiffness.

Kind
Randomized trial
Studied in
People
Number studied
36
Published
2023
Journal
Sci Rep

What they tested

The team tested whether taking NMN (nicotinamide mononucleotide, a building block the body uses to make NAD+) by mouth for 12 weeks changes NAD+ metabolism and other blood and health measures in healthy adults.

How the study was done

A randomized, double-blind, placebo-controlled trial in 36 healthy middle-aged adults. For 12 weeks, people took one capsule of either 125 mg NMN or a placebo (a dummy capsule) twice a day.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Of the NAD+-related compounds measured, serum nicotinamide was significantly higher in the NMN group than in the placebo group. Pulse wave velocity, a measure of arterial stiffness, trended lower with NMN, but the difference between the groups was not significant. The 250 mg/day intake was well tolerated, with no adverse events.

What it doesn’t show

This was a small, 12-week trial in healthy middle-aged people only, so it can't show effects in older or sick people or over longer periods. The arterial stiffness change did not reach significance, so it is not an established effect.

The paper

Katayoshi et al. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial. Sci Rep. 2023.

The compounds

More studies on NAD+

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo